Abstract
In our hospital, 83 patients with colorectal cancer underwent the immunologic fecal occult blood test (IFOBT). The positive rate for IFOBT in all patients was 87%. Colon cancers more proximal than the transverse colon were 100% positive. Carcinomas of the ulcerative type showed a significantly higher positive rate than those of the non-ulcerative type (94% vs 73%). Carcinomas penetrating the muscularis or beyond showed a significantly higher positive rate, of 96% (52/54 cases) compared to carcinomas confined to the mucosa or submucosa, which gave positive rates of 64% and 60%, respectively. In the investigation of the 7 patients with colorectal cancer who showed negative results on the IFOBT, IFOBT had been performed only once in of these patients. Accordingly, it was considered necessary to perform IFOBT more than once. The cancers in 5 of these 7 patients were found to be carcinomas confined to the mucosa. This result suggests the advisability of annual IFOBTs. It is also considered necessary to manage patients who show undefinable but possibly positive (±) results with caution.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Statistics and information Department, Minister's Secretariat, Ministry of Health and Welfare. Vital Statistics 1985 Japan. 1985;1:248–263.
Saito H, Tsuchida S, Fujita H, et al An immunological test for fecal occult blood by counter immunoelectrophoresis. Jpn Gastroenterol 1982;79:1944–1949.
Saito H, Tsuchida S, Fukushi M, et al. An immunological test for fecal occult blood by counter immunoelectrophoresis: A following report. Jpn J Gastroenterol 1984;81:2935–2939.
Hagiwara H, Shimonaka M, Sakurai Y, et al. Immunochemical detection of human denatured hemoglobin in occult blood. Clin Chim Acta 1984;136:245–249.
Saito H, Tsuchida S, Nakajima S, et al. An immunologic test for fecal occult blood by counter immunoelectrophoresis. Cancer 1985;56:1549–1552.
Turnen MJ, Liewendahl K, Partanen P, et al. Immunological detection of fecal occult blood in colorectal cancer. Br J Cancer 1984;49:141–148.
Songster CL, Barrows GH, Jarrett DD, MT ASCP. Immunochemical detection of fecal occult blood. Cancer 1980;45:1099–1102.
Saito H, Tsuchida S, Kakizaki R, et al. An immunological fecal occult blood test for mass screening of colorectal cancer by reversed passive hemagglutination (RPHA). Jpn J Gastroenterol 1984;81:2831.
Adams EC, Layman KM. Immunochemical confirmation of gastrointestinal bleeding. Ann Clin Lab Sci 1974;4:343–349.
Takeshita T, Horiguchi J, Kinoshita T, et al Latex agglutination test for fecal occult blood. J Jpn Soc Colo-Proctol 1985;38: 780–783.
Adlercreutz H. Is specific detection of human hemoglobin (h-Hb) in feces a solution to the problem of occult blood (OB) testing for detection of colorectal cancer? Scand J Gastroenterol 1982:17:329.
Adlercreutz H, Partanen P, Virkola P, et al. Five guaiac-based tests for occult blood in facces compared in vitro and in vivo. Scand J Clin Lab Invest 1984;44:519–528.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Iida, Y., Munemoto, Y., Miura, S. et al. Clinicopathologic studies of immunologic fecal occult blood test for colorectal cancer. J Gastroenterol 30, 195–200 (1995). https://doi.org/10.1007/BF02348665
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF02348665